Glutamine pathway helps dormant prostate cancer cells survive and recur
A quiet biochemical switch may explain why prostate cancer can return years after treatment appears to have succeeded. New research ...
A quiet biochemical switch may explain why prostate cancer can return years after treatment appears to have succeeded. New research ...
Multiple myeloma has long challenged researchers because the disease is not driven only by uncontrolled growth. Its malignant plasma cells ...
Ewing sarcoma, an aggressive cancer that predominantly affects children and adolescents, has long challenged researchers because of its ability to ...
Glioblastoma is among the most aggressive and difficult-to-treat brain cancers, and a new study is drawing attention to an unexpected ...
Gastric cancer remains one of the world’s most lethal malignancies, and its treatment is increasingly threatened by resistance to cisplatin, ...
In a groundbreaking study poised to reshape cancer therapy paradigms, researchers have uncovered a critical molecular player, TATA box-binding protein-associated ...
A groundbreaking advancement in cancer treatment has emerged from a collaborative preclinical study conducted by renowned Spanish research institutions, the ...
In a groundbreaking development that could redefine therapeutic paradigms in oncology, researchers have unveiled a novel molecular mechanism that tackles ...
In a groundbreaking preclinical study that could redefine therapeutic approaches to lung cancer, researchers at The University of Texas MD ...
In a groundbreaking study poised to reshape our understanding of pancreatic cancer biology, researchers have unveiled how the epigenetic landscape ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine